|
ZNF320 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.476990E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.280220E-02 |
| Normal-vs-Stage2 |
1.286200E-02 |
| Normal-vs-Stage3 |
6.833900E-04 |
| Normal-vs-Stage4 |
1.317290E-03 |
| Stage1-vs-Stage2 |
5.877600E-01 |
| Stage1-vs-Stage3 |
1.532770E-01 |
| Stage1-vs-Stage4 |
1.475610E-01 |
| Stage2-vs-Stage3 |
6.178200E-01 |
| Stage2-vs-Stage4 |
5.544000E-01 |
| Stage3-vs-Stage4 |
8.933800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.696200E-03 |
| Normal-vs-AfricanAmerican |
7.381900E-02 |
| Normal-vs-Asian |
1.456370E-01 |
| Caucasian-vs-AfricanAmerican |
8.375200E-01 |
| Caucasian-vs-Asian |
2.607600E-01 |
| AfricanAmerican-vs-Asian |
5.382000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.121400E-03 |
| Normal-vs-Female |
2.699300E-03 |
| Male-vs-Female |
8.169800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.568200E-02 |
| Normal-vs-Age(41-60Yrs) |
9.795800E-04 |
| Normal-vs-Age(61-80Yrs) |
1.139070E-03 |
| Normal-vs-Age(81-100Yrs) |
2.301600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.667630E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.830970E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.305400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.690000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.237400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.696400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.274230E-01 |
| Classical-VS-Follicular |
3.337100E-03 |
| Classical-VS-Other |
3.026000E-01 |
| Classical-VS-Normal |
2.684000E-02 |
| Tall-VS-Follicular |
6.621000E-01 |
| Tall-VS-Other |
7.879800E-01 |
| Tall-VS-Normal |
5.862700E-03 |
| Follicular-VS-Other |
9.829600E-01 |
| Follicular-VS-Normal |
3.372100E-04 |
| Other-VS-Normal |
7.918400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.984200E-04 |
| Normal-vs-N1 |
3.129600E-02 |
| N0-vs-N1 |
3.968000E-01 |
|
|
